Clinical trial
A Research Study to Compare the Treatments of a Combination of Elzasonan With…
NCT00275197 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00275197 |
|---|---|
| Title | A Research Study to Compare the Treatments of a Combination of Elzasonan With Zoloft, to Zoloft Alone, or Placebo in People With Major Depressive Disorder (MDD) |
| Official title | An Eight-Week, Double-Blind, Group-Sequential Design, Placebo Controlled Trial To Evaluate The Safety And Efficacy Of The Co- Administration Of Sertraline And Elzasonan (CP-448,187) In Outpatients With Major Depressive Disorder |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Depressive Disorder, Major |
| Intervention type | Drug |
| Interventions | Sertraline and Elzasonan Combination, Sertraline, Placebo |
| Enrollment | 262 |
| Start date | Dec 1, 2005 |
| Completion | Jul 1, 2007 |
| First posted | Jan 11, 2006 |
| Last update posted | Nov 3, 2008 |
| Countries | Chile, Estonia, Russia, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: